Department of Hematology

Hematology Home >

Faculty

Naomi B. Haas, MD

Associate Professor of Medicine at the Hospital of the University of Pennsylvania

Department: Medicine

Contact information

16 Penn Tower
3400 Spruce Street
Philadelphia, PA 19104

Office: 215-662-7402
Fax: 215-349-8550

Email:
naomi.haas@uphs.upenn.edu

Education:
M.D.
Northeastern Ohio Universities College of Medicine, 1985.
B.S. (Integrated Life Sciences)
Kent State University, 1985.

Post-Graduate Training
Resident, Abington Memorial Hospital, 1985-1988.
Fellow, Temple University/Fox Chase Cancer Center, 1988-1991.
Fellow, Fox Chase Cancer Center- Institute for Cancer Research, 1992-1995.
Fellow, Fox Chase Cancer Center, 1995-2000.

Certifications
American Board of Internal Medicine, 1988.
American Board of Internal Medicine, Medical Oncology, 1995.
Medical Oncology Recertification, 2005.

Permanent link

> School of Medicine > Faculty > Details

Selected Publications

Yu JQ, Milestone BD, Parsons RB, Doss M, Haas N: Findings of Intra-Mediastinal Gossypiboma with F-18 FDG PET in a Melanoma Patient. CLinical Nuclear Medicine 33(5): 344-345, 2008.

Dreicer, R., Li, S., Manola, J., Haas, N.B., Roth, B.J., Wilding, G.: A Phase II Trial of Epothilone B Analogue BMS-247550 (Ixabepilone) in Advanced Carcinoma of the Urothelium (E3800): A Trial of the Eastern Cooperative Oncology Group. Cancer 110(4): 759-763, 2007.

Haas, N.B., and Uzzo, R.G.: Targeted Therapies for Kidney Cancer in Urologic Practice. Urologic Oncology 25(5): 420-432, 2007.

Haas, N.B. and Uzzo, R.G.: A Randomized, Double Blind Phase III Trial of Adjuvant Sunitinib versus Sorafenib versus Placebo in Patients with Resected Renal Cell Carcinoma,US Genito-urinary Disease. 2007.

Wong, Y.N., Suh, B., Parsons, R., Telivala, B., Haas, N., Greenberg, R.: Emphysematous pyelonephritis caused by Pasteurella multocida following renal embolization for renal cell cancer: A case report, in press. 2007.

Haas, N.B. and Uzzo, R.G.: A Randomized, Double Blind Phase III Trial of Adjuvant Sunitinib versus Sorafenib versus Placebo in Patients with Resected Renal Cell Carcinoma,US Genito-urinary Disease. ECOG 2805(2), 2007.

Houghton, A.N., Coit, D.G., Daud, A., Dilawari, R.A., Dimaio, D., Gollob, J.A., Haas, N.B., Halpern, A., Johnson, T.M., Kashani-Sabet, M., Kraybill, W.G., Lange, J.R., Martini, M., Ross, M.I., Samlowski, W.E., Sener, S.F., Tanabe, K.K., Thompson, J.A., Trisal, V., Urist, M.M., Walker, M.J. : Melanoma. Journal of the National Comprehensive Cancer Network 4(7): 666-684, 2006.

Yao, K., Gietema J.A., Shida S., Selvakumaran M., Fonrose, X., Haas, N.B., Testa, J., O’Dwyer, P.J.: Macrophage Migration Inhibitory Factor (MIF) is a determinant of hypoxia-induced apoptosis in colon cancer cell lines. Clinical Cancer Research 11(20): 7264-7272, 2005.

Yao, K., Gietema, J.A., Shida, S., Selvakumaran, M., Fonrose, X., Haas, N.B., Testa, J., O'Dwyer, P.J.: In vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo. British Journal of Cancer 93(12): 1356-1363, 2005.

Rowinsky, E., Schwartz, G., Gollob, J., Thompson, J., Vogelzang, N., Figlin, R., Bukowski, R., Haas, N., Lockbaum, P., Li, Y.P., Arends, R., Foon,, K., Schwab, G., Dutcher, J.: Safety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancer. Journal of Clinical Oncology 22: 3003-3015, 2004.